Anavex Life Sciences Corp (AVXL)

[baltimorebullet]

It says below seizures and sleep problems are symptoms.
When you all talk about a master protocol do you mean one or all of the trials will have common endpoints like seizure reduction, insomnia relief, improved cognition... and then A-273 could be FDA approved for other diseases automatically even though Anavex believes it may in fact help the afflicted people in a much more profound way?

Hope the above makes sense.


Angelman syndrome (AS) is a genetic disorder that mainly affects the nervous system.[2] Symptoms include a small head and a specific facial appearance, severe intellectual disability, developmental disability, speech problems, balance and movement problems, seizures, and sleep problems.[2] Children are usually happy in nature and have a particular interest in water.[2] The symptoms generally become noticeable by one year of age.[2]